Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,713 | 10,229 | 38,500 | 47,086 | 35,004 |
| Marketable Securities | 37,856 | 53,176 | 54,927 | 51,097 | 52,321 |
| Receivables | 61,527 | 120,110 | 141,307 | 61,090 | 66,292 |
| Inventories | 23,010 | 24,120 | 24,763 | 32,880 | 39,403 |
| TOTAL | $166,855 | $216,646 | $263,573 | $210,209 | $213,550 |
| Non-Current Assets | |||||
| PPE Net | 408 | 444 | 479 | 515 | 550 |
| Intangibles | 43,104 | 48,908 | 54,711 | 62,006 | 71,238 |
| Other Non-Current Assets | 932 | 972 | 1,012 | 1,050 | 1,088 |
| TOTAL | $44,444 | $50,324 | $56,202 | $63,571 | $72,876 |
| Total Assets | $211,299 | $266,970 | $319,775 | $273,780 | $286,426 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,913 | 9,014 | 14,664 | 10,854 | 8,896 |
| Accrued Expenses | 80,829 | 113,648 | 146,799 | 116,942 | 115,167 |
| Other current liabilities | N/A | N/A | 5,320 | 4,733 | 4,769 |
| TOTAL | $91,573 | $127,513 | $166,783 | $132,529 | $128,832 |
| Non-Current Liabilities | |||||
| Long Term Debt | 39,249 | 39,124 | 39,166 | 39,046 | 38,929 |
| Other Non-Current Liabilities | 4,845 | 6,381 | 8,023 | 8,907 | 10,135 |
| TOTAL | $44,094 | $45,505 | $47,189 | $47,953 | $49,064 |
| Total Liabilities | $135,667 | $173,018 | $213,972 | $180,482 | $177,896 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,462 | 6,445 | 6,420 | 6,419 | 6,389 |
| Common Shares | 1 | 1 | 9 | 9 | 9 |
| Retained earnings | -722,355 | -703,499 | -691,572 | -703,017 | -686,665 |
| TOTAL | $75,632 | $93,952 | $105,803 | $93,298 | $108,530 |
| Total Liabilities And Equity | $211,299 | $266,970 | $319,775 | $273,780 | $286,426 |